fda compounding semaglutide enforcement news november 2025 Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots Compounded "semaglutide" is not FDA-approved

Because of this, many GLP-1 users have experienced nutritional deficiencies, leading to additional health issues (4)

Furthermore, extensive clinical trials with Ozempic have revealed significant cardiovascular benefits, including a reduced risk of major cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes who have cardiovascular risk factors

Additionally, slowed stomach emptying can lead to bacterial overgrowth in the small intestine, producing gas and loose stools

Associations between the rate, amount, and composition of weight loss as predictors of spontaneous weight regain in adults achieving clinically significant weight loss: a systematic review and meta-regression

Data on weight loss, diabetes management, and other health outcomes is essential for comprehending the long-term effects and effectiveness of these medications

The competitive startup world can be a strange place for a new medication to proliferate, Chastain points out, because of the pressure from venture capital investors to scale